Volvox Therapeutics is a private virtual biotechnology development company focusing on generating, creating and re-creating value from „fallen angel“ and „hidden treasure“ compounds that have fallen off development or lost their priority status due to issues occurring during early development stages. The company is focused on salvaging these compounds and carry them into the next development step thus creating value for patients and investors. Volvox was founded by an experienced management team with significant expertise in all phases of development and broad network of high caliber individuals and top advisors. Volvox key expertise is in oncology and immunology.
Volvox Therapeutics GmbH
Volvox goes US
Volvox proudly announces the foundation of its first US affiliate. Susavox Biotechnologies, Inc.